Hologic (NASDAQ:HOLX) reported quarterly earnings results on January 29, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $1.04, missing the consensus estimate of $1.10 by $0.06 per share. Revenue came in at $1.0B, missing the estimate of $1.1B.
Hologic's stock moved following the earnings release. The stock currently trades at $74.74 with a market capitalization of $16.7B.